Symbols

CSBR

Champions Oncology·NASDAQ

--(--)

7.05 / 10

Outperform

Analyst coverage is absent, but fund‑flow analysis rates CSBR at 7.05/10 (good). Overall, block, medium and extra‑large investors show strong inflows, while small and large investors are net sellers. Liquidity remains positive, supporting the Outperform outlook.

Fund Flow Rating

Is money flowing into or out of CSBR?

CSBR holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.05/10 (Outperform).